There you have it:QUOTING GSK:Sales of flu anti-viral Relenza fell 80% to £57 million, reflecting fewer government orders for stockpiling. Surely Peter Cook cant blame this on poor northern seasonal flu season!!
MKT The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint